First over-the-counter preservative-free antihistamine eye drops FDA approved for the relief of itchy eyes associated with allergies
Deployment now to major US retailers
LAVAL, QC, February 23, 2021 / PRNewswire / – Bausch & Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE / TSX: BHC) (“Bausch Health”), today announced the launch of Alaway at United States® Preservative-Free Antihistamine Eye Drops (0.035% Ketotifen Fumarate Ophthalmic Solution), the first and only over-the-counter (OTC) preservative-free (OTC) antihistamine eye drops for the relief of itchy eyes approved by the United States Food and Drug Administration.
“As we head into spring, millions of Americans with allergies will experience itchy eyes, one of the eye symptoms that affects about 80% of allergy sufferers,”1 said Joe Gordon, US president of Bausch + Lomb. “With the availability of Alaway® Preservative-Free Antihistamine Eye Drops Consumers now have a new over-the-counter option that provides fast, long-lasting relief from itchy eyes without the use of preservatives. “
During allergy season, irritating particles in the air, such as pollen, can cause the eyes to release histamine which can cause swelling and itchy eyes. Far away® Preservative Free is a new prescription OTC formula that is formulated to block the release of histamine and reduce allergic inflammation. Working directly at the source of the itchy eye symptoms, Alaway provides relief in minutes and lasts up to 12 hours with a single dose.
“Many of my patients who have seasonal or perennial allergies tend to rely on oral allergy medications to treat their symptoms. However, oral allergy medications may not provide them with the relief from the itchy eye that they have. need “said Arthur epstein, OD, Director of Clinical Research, Phoenix Eye Care, Arizona. “In the distance® is a proven antihistamine eye drop that gives patients fast, long-lasting relief from itchy eyes where they need it. Now with the Alaway without preservative® formula, allergy sufferers now have a new option with less risk of irritation associated with preservatives to help relieve their itchy eye symptoms. “
Alaway Preservative Free will be available for purchase at most nationwide retailers, including Walgreens, CVS, Walmart, and Amazon. A 10 day supply (20 single dose vials) will have a manufacturer’s suggested retail price of $ 14.99.
For more information on Alaway® eye drops, visit www.alaway.com.
About Bausch + Lomb
Bausch + Lomb, one of the leading global eye health companies of Bausch Health Companies Inc., is all about helping people see better, live better. Its core businesses include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the industry’s most comprehensive product portfolios, available in approximately 100 countries. For more information visit www.bausch.com.
About Bausch Santé
Bausch Health Companies Inc. (NYSE / TSX: BHC) is a global company with a mission to improve people’s lives through our health care products. We develop, manufacture and market a range of pharmaceuticals, medical devices and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We deliver on our commitments by building an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.
This press release may contain forward-looking statements, which can generally be identified by the use of the words “expects”, “expects”, “intends”, “plans”, “should”, “could”, “Could”, “” may “,” believe “,” estimate “,” potential “,” target “or” continuing “and variations or similar expressions. These statements are based on the current expectations and beliefs of management and are subject to certain risks and uncertainties which could cause actual results to differ materially from those described in forward-looking statements. These risks and uncertainties include, without limitation, the risks and uncertainties discussed in Bausch Health’s most recent annual report on Form 10-K and detailed from time to time in other documents filed by Bausch Health with the Securities. and Exchange Commission of the United States and the Canadian Commission of Securities Administrators, which factors are incorporated herein by reference. They also include, but are not limited to, the risks and uncertainties caused by or related to the course of the COVID-19 pandemic, and the fear of this pandemic and its potential effects, including severity, duration. and the future impact are highly uncertain and cannot be predicted, and which may have a material negative impact on Bausch Health, including, but not limited to, the development times of its projects and costs (which may increase ). Readers are cautioned not to place undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date hereof. Bausch Health assumes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual results, except as required by law.
1. The 2018 U.S. Allergy Study, Multi-sponsor Surveys, Inc. February 2018.
Alaway is a registered trademark of Bausch & Lomb Incorporated or its affiliates.
All other product / brand names and / or logos are trademarks of their respective owners.
© 2021 Bausch & Lomb Incorporated or its affiliates.
View original content to download multimedia:http://www.prnewswire.com/news-releases/bausch–lomb-launches-alaway-preservative-free-antihistamine-eye-drops-301232944.html
SOURCE Bausch Health Companies Inc.